Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -0.40 (-0.40%)
Bid:
100.00
Ask:
100.40
Spread: 0.40 (0.40%)
Market Cap: £420.35m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

10 Dec 2014 07:00

RNS Number : 2812Z
PZ CUSSONS PLC
10 December 2014
 

10 December 2014

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2014.

 

First half trading

 

Operating profits in Europe and Asia were higher than the comparative period last year, however they were lower in Africa as a result of challenging trading conditions and the devaluation of the Naira towards the end of the period. Taken together Group operating profits were 4% below that of the comparative period.

 

Excluding the impact of exchange rates, operating profits were flat period on period, comprising good organic growth in the underlying business together with the positive impact of the Five:AM acquisition offsetting the reduction in profits from Poland as a result of last year's Home Care brands sale.

 

The financial position of the Group remains strong with cash generation during the period in line with expectations.

 

Trading - Update

 

Europe

 

In the UK, performance in the washing and bathing division has been strong despite challenging trading conditions and driven by an exciting innovation pipeline. Highlights in the period include the relaunch of the entire Imperial Leather range and the launch of a new range of body care products under the Original Source brand.

 

In the beauty division, performance has been good with growth in the US and Australia offsetting tougher trading conditions in the UK.

 

Performance in the smaller markets of Poland and Greece was in line with expectations.

 

Asia

 

In Indonesia, the babycare portfolio has been expanded in the period with the launch of new products whilst non-babycare brands such as Original Source are performing well.

 

Performance in Australia has been good across the categories of Home Care, Personal Care, Beauty and Food & Nutrition. Five:AM, the food brand acquired in August for £44.1m in cash, is performing very well. The international expansion of Rafferty's Garden, acquired last year, has commenced with the launch of the range into the New Zealand market.

 

Africa

 

In Nigeria, disruption in the north of the country has continued at a high level, resulting in a decline in sales in that region. Good growth has continued in the south of the country, in particular in the electrical goods business and in the two food and nutrition joint ventures. Whilst Nigeria has been declared Ebola free, there has been a negative impact on cross-border trade.

 

Overall operating profits in Nigeria were lower than the comparative period both as a result of tough trading conditions, particularly in the North, and of the 8% devaluation of the Naira towards the end of the period.

 

Performance in the smaller markets of Ghana and Kenya was in line with expectations.

 

Full year outlook

 

The macro environment in Nigeria in the second half, which includes the February presidential elections and potential further currency volatility, will be a key contributing factor to the overall result for the full year.

 

The Group remains focussed on a dynamic and fast brand renovation and innovation programme, an ongoing cost reduction programme and successful delivery of new areas of growth such as Rafferty's Garden, Five:AM and the PZ Wilmar joint venture.

 

These initiatives will contribute towards offsetting the continuing macro challenges, particularly in Nigeria, and the reduction in profits from Poland as a result of last year's Home Care brands sale.

 

Interim Announcement

 

Interim results for the half year to 30 November 2014 will be announced on Tuesday 27th January 2015.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Investec, 2 Gresham Street, London, EC2V 7QP.

 

- ENDS -

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1236

Brandon Leigh - Chief Financial Officer

 

Instinctif Tel: 020 7457 2020

Toby Bates / Tim Linacre

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGBPPUPCGAB
Date   Source Headline
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale
25th Sep 20193:57 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Statement
29th Aug 20197:00 amRNSProposed sale of Minerva and Luksja brand
23rd Aug 201912:15 pmRNSPublication of ARA and Notice of AGM
26th Jul 20198:45 amRNSDirector/PDMR Shareholding
23rd Jul 20197:00 amRNSFinal Results
13th Jun 20197:00 amRNSBoard Change
13th Jun 20197:00 amRNSTrading update
30th Apr 20195:30 pmRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSTrading Update
28th Mar 201912:15 pmRNSDirector Declaration
14th Mar 201910:00 amRNSPZ Cussons Plc Director Declaration
30th Jan 201911:10 amRNSInterim Dividend Payment Date
29th Jan 20197:00 amRNSHalf-year Report
23rd Jan 20198:10 amRNSDirector Declaration
13th Dec 20187:00 amRNSTrading Update
13th Nov 201811:09 amRNSHolding(s) in Company
26th Sep 20184:25 pmRNSResult of AGM
26th Sep 20187:00 amRNSAGM Trading Statement
6th Aug 20185:30 pmRNSDirector/PDMR Shareholding
30th Jul 20185:19 pmRNSDirector/PDMR Shareholding
26th Jul 20184:05 pmRNSDirector/PDMR Shareholding
26th Jul 20183:15 pmRNSDirector/PDMR Shareholding
24th Jul 20187:00 amRNSFinal Results
14th Jun 20187:00 amRNSTrading update
2nd May 20187:00 amRNSChange to the Board of Directors
15th Mar 20187:00 amRNSTrading Update
30th Jan 20187:00 amRNSInterim Results
4th Jan 20184:41 pmRNSDirectorate Change
14th Dec 20177:00 amRNSTrading Update
7th Dec 201710:42 amRNSHolding(s) in Company
5th Dec 201710:49 amRNSHolding(s) in Company
27th Sep 20175:30 pmRNSAGM Statement
27th Sep 20177:00 amRNSAGM Trading Statement
30th Aug 20175:30 pmRNSDirector/PDMR Shareholding
28th Jul 20175:30 pmRNSHolding(s) in Company
27th Jul 201711:03 amRNSDirector/PDMR Shareholding
25th Jul 20177:01 amRNSBoard Changes
25th Jul 20177:00 amRNSFinal Results
15th Jun 20177:00 amRNSTrading Update
13th Apr 20177:00 amRNSTrading Update
24th Mar 20177:00 amRNSAppointment of Deloitte LLP as Auditor
13th Mar 201712:24 pmRNSDirector/PDMR Shareholding
1st Feb 20178:45 amRNSDirector/PDMR Shareholding
26th Jan 20175:30 pmRNSDirector/PDMR Shareholding
25th Jan 20175:30 pmRNSDirector/PDMR Shareholding
24th Jan 20177:00 amRNSHalf-year Report
15th Dec 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.